On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis

Cancer and Metastasis Reviews

Volumn 20, Issue 3-4, 2001, Pages 245-277

  Gorelik, Elieser ^a   Galili, Uri ^b   Raz, Avraham ^c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Carbohydrate; Galectin; Glycoprotein; Lectin; Metastasis

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; CARBOHYDRATE; CASTANOSPERMINE; COMPLEMENTARY DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GALECTIN; GANGLIOSIDE GD3; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; GROWTH FACTOR; LECTIN; LIGAND; N ACETYLGLUCOSAMINYLTRANSFERASE; PADGEM PROTEIN; SIALIDASE; TRANSCRIPTION FACTOR; TUNICAMYCIN; VASCULOTROPIN;

ANIMAL MODEL; APOPTOSIS; CYTOTOXICITY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GLYCOSYLATION; HUMAN; IMMUNE SYSTEM; KNOCKOUT MOUSE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0035740634     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015535427597     Document Type: Review

References (209)

1. Concepts and principles of glycobiology
2. Carbohydrates
3. Lectins as cell recognition molecules
4. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives
5. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
6. N-linked oligosaccharide processing and tumor cell biology
7. Changes in glycosylation associated with malignant transformation and tumor progression
8. Asn-linked oligosaccharide-dependent interaction between laminin and gp120/140. An alpha 6/beta 1 integrin
9. Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA 169 cells
10. Analysis of the role of glycosylation of the human fibronectin receptor
11. Structure of glycoproteins and their oligosaccharide units
12. Cytotoxic effects of antigen-and mitogen-induced T cells on various targets
13. Use of lectins as mitogens for lymphocytes
14. Mitogenic effects of lectins on epithelial cells
15. Effects of lectins on cytoskeletal organization in mammalian cells
16. Effect of lectins on protein kinase activity
17. Carbohydrate-binding proteins (plant/human lectins and autoantibodies from human serum) as mediators of release of lysozyme, elastase, and myeloperoxidase from human neutrophils
18. Surface carbohydrate alterations of mutant mammalian cells selected for resistance to plant lectins
19. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants
20. Lectin-resistant variants of mouse melanoma cells. I. Altered metastasizing capacity and tumorigenicity
21. Non-metastasising variants selected from metastasising melanoma cells
22. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
23. Galectins. Structure and function of a large family of animal lectins
24. Biology of animal lectins
25. Increasing diversity of animal lectin structures
26. Selectin ligands
27. Galectins: An evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy
28. Possible roles of tumor-associated carbohydrate antigens
29. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens
30. Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression
31. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis and vascular endothelial growth factor production
32. Gangliosides influence angiogenesis in an experimental mouse brain tumor
33. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody
34. Identification of a human neuroectodermal tumor antigen (OFA-1-2) as ganglioside GD2
35. Glycolipid antigen associated with Burkitt's lymphoma defined by a monoclonal antibody
36. Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's disease
37. Vascular endothelial growth factor production is stimulated by gan gliosides and TGF-beta isoforms in human glioma cells in vitro
38. Anglogenesis can be stimulated or repressed in vivo by a change in GM3: GD3 ganglioside ratio
39. Angiogenesis in cancer, vascular, rheumatoid and other disease
40. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia
41. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri-and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells
42. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis
43. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts
44. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation
45. Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1
46. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene
47. Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development
48. Beta 1-6 branching of N-linked carbohydrate is associated with K-ras mutation in human colon carcinoma cell lines
49. Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients
50. Increased CMP-NeuAc:Gal beta 1,4GlcNAc-Rs alpha 2,6 sialyltransferase activity in human colorectal cancer tissues
51. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma
52. The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells
53. Genetics of ABO, H, Lewis, X and related antigens
54. Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression
55. Expression of histo-blood-group-A/B-gene-defined glycosyltransferases in normal and malignant epithelia: Correlation with A/B-carbohydrate expression
56. Carbohydrate changes in bladder carcinomas
57. Expression of blood-group antigen A-a favorable prognostic factor in non-small-cell lung cancer
58. Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue
59. Loss of isoantigens A, B, and H in carcinoma of the lung
60. Isoantigens A, B, and H in benign and malignant lesions of the cervix
61. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines
62. Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas
63. Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy
64. Histo-blood group A/B versus H status of human carcinoma cells as correlated with haptotactic cell motility: Approach with A and B gene transfection
65. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma
66. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung
67. Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study
68. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression
69. Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: Role of sialyl-LeX antigens
70. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials
71. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer
72. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines
73. Different patterns of lectin binding and cell surface sialylation detected on related high-and low-metastatic tumor lines
74. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation
75. Cell surface properties of high-and low-metastatic cell lines selected from a spontaneous mouse lung carcinoma
76. Cell surface sialylation and tumor metastasis. Metastatic potential of B 16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures
77. Control of metastasis by Asn-linked, beta1-6 branched oligosaccharides in mouse mammary cancer cells
78. Asn-linked oligosaccharides in lectin-resistant tumor-cell mutants with varying metastatic potential
79. The role of protein glycosylation inhibitors in the prevention of metastasis and therapy of cancer
80. Inhibitors of carbohydrate processing: A new class of anticancer agents
81. Inhibition of experimental metastasis by castanospermine in mice: Blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors
82. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells
83. Effects of tuni-camycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties
84. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression
85. Inhibition of v-fms-induced tumor growth in nude mice by castanospermine
86. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator
87. Protective effects of swainsonine on murine survival and bone marrow proliferation during cytotoxic chemotherapy
88. Cell surface properties of B 16 melanoma variants with differing metastatic potential
89. Carbohydrate chain analysis by lectin binding to electrophoretically separated glycoproteins from murine B 16 melanoma sublines of various metastatic properties
90. Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70
91. Selection and in vivo properties of lectin-attachment variants of malignant murine lymphosarcoma cell lines
92. Mechanisms of cytotoxic activity of lectins
93. Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice
94. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors
95. Effects of H-2Kb gene on expression of melanoma-associated antigen and lectin-binding sites on BL6 melanoma cells
96. Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection
97. Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection
98. Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: Immunological and nonimmunological mechanisms
99. Carbohydrate binding studies on the Bandeiraea simplicifolia I isolectins. Lectins which are mono-, di-, tri-, and tetravalent for N-acetyl-D-galactosamine
100. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells
101. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody
102. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: A major obstacle for xenotransplantation in humans
103. Transfer and expression of a murine UDP-Gal:beta-D-Gal-alpha 1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the alpha 1,3-galactosyltransferase and the endogenous alpha 2,3-sialyltransferase
104. A cloned human DNA restriction fragment determines expression of a GDP-L-fucose: Beta-D-galactoside 2-alpha-L-fucosyltransferase in transfected cells. Evidence for isolation and transfer of the human H blood group locus
105. Characterization of a deficiency in fucose metabolism in lectin-resistant variants of a murine tumor showing altered tumorigenic and metastatic capacities in vivo
106. Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection
107. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells
108. Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells
109. Increased tumorigenicity of rat colon carcinoma cells after alpha 1,2-fucosyltransferase FTA anti-sense cDNA transfection
110. Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus
111. Evidence for two distinct alpha(1,2)-fucosyltransferase genes differentially expressed throughout the rat colon
112. Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms
113. Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion
114. Redirection of tumor metastasis by expression of E-selectin in vivo
115. Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice
116. Overexpression of alpha 1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice
117. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas
118. Suppression of lung metastasis of B 16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection
119. Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization
120. Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain
121. Suppression of pulmonary metastasis in murine B 16 melanoma cells by transfection of a sialidase cDNA
122. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431
123. Reduced cell migration, tumor growth and experimental metastasis of rat F-11 cells whose expression of GD3-synthase is suppressed
124. Alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies
125. Growth retardation and early death of beta-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells
126. Suppression of tumor growth and metastasis in Mgat5-deficient mice
127. God must love galectins; he made so many of them
128. Evolutionary conservation of intron position in a subfamily of genes encoding carbohydrate-recognition domains
129. The C-type lectin superfamily in the immune system
130. Collectins: Pattern recognition molecules involved in first line host defense
131. Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera
132. The mannose receptor is a pattern recognition receptor involved in host defense
133. Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: Characterization and evidence for receptor recycling
134. Orientation of sugars bound to the principal C-type carbohydrate-recognition domain of the macrophage mannose receptor
135. Adhesion molecules controlling lymphocyte migration
136. The selectins: Vascular adhesion molecules
137. L-selectin binds to P-selectin glycoprotein ligand-1 on leukocytes: Interactions between the lectin, epidermal growth factor, and consensus repeat domains of the selectins determine ligand binding specificity
138. Type II integral membrane proteins with characteristics of C-type animal lectins expressed by natural killer (NK) cells
139. Galectin-3 induces endothelial cell morphogenesis and angiogenesis
140. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin
141. Endogenous galactoside-binding lectins: A new class of functional tumor cell surface molecules related to metastasis
142. Molecular cloning and chromosomal mapping of a human galactoside-binding protein
143. Galectins: A family of animal beta-galactoside-binding lectins
144. Galectin-3 is a nuclear matrix protein which binds RNA
145. Identification of galectin-3 as a factor in pre-mRNA splicing
146. Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic and metastatic cells
147. Modulation of galactoside-binding lectins in tumor cells by differentiation-inducing agents
148. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon
149. Expression of galectins in head and neck squamous cell carcinoma
150. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system
151. Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas
152. Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma
153. Decreased expression of galectin-3 is associated with progression of human breast cancer
154. Serum lectin with known structure activates complement through the classical pathway
155. The human mannose-binding protein functions as an opsonin
156. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella
157. Impaired secretion of rat mannose-binding protein resulting from mutations in the collagen-like domain
158. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
159. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection
160. Lectin-induced apoptosis of tumour cells
161. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes
162. Apoptosis of T cells mediated by galectin-1
163. Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis
164. Expression of galectin-3 modulates T-cell growth and apoptosis
165. Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
166. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells
167. L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion
168. Tissue fibronectin is an endogenous ligand for galectin-1
169. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion
170. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion
171. Disruption of epithelial cell-matrix interactions induces apoptosis
172. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells
173. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: Liver colonization and adhesion to vascular endothelial cells
174. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line
175. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: The importance of surface sialyl Lewis(a) antigen
176. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells
177. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis
178. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells
179. Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin
180. Peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells
181. Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells
182. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer
183. P-selectin deficiency attenuates tumor growth and metastasis
184. Interaction of the hemostatic and immune systems in the metastatic spread of tumor cells
185. Role of NK cells in the antimetastatic effect of anticoagulant drugs
186. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice
187. Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes
188. Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression
189. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3
190. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma lines
191. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3
192. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells
193. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis
194. Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization
195. Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose
196. Effect of lactose derivatives on metastatic potential of B 16 melanoma cells
197. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin
198. Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions
199. Distribution of membrane anionic sites on B 16 melanoma variants with differing lung colonising potential
200. Expression of the integrin alpha 4beta1 on melanoma cells can inhibit the invasive stage of metastasis formation
201. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: Mannan-binding proteindependent cell-mediated cytotoxicity
202. Distribution of murine mannose receptor expression from early embryogenesis through to adulthood
203. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro
204. Mannose receptor-mediated endothelial cell activation contributes to B 16 melanoma cell adhesion and metastasis in liver
205. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products
206. The biology of cancer invasion and metastasis
207. Cancer cell invasion and metastasis
208. Differential colon cancer cell adhesion to E-, P-, and L-selectin: Role of mucin-type glycoproteins